Bio Solution Co.,Ltd. (KOSDAQ:086820)
6,200.00
-180.00 (-2.82%)
At close: Jul 28, 2026
Bio Solution Market Cap
Bio Solution has a market cap or net worth of 159.99 billion as of July 28, 2026. Its market cap has decreased by -19.71% in one year.
Market Cap
159.99B
Enterprise Value
168.26B
Revenue
15.82B
Ranking
n/a
PE Ratio
229.53
Stock Price
6,200.00
ChartMarket Cap Chart
Since August 20, 2018, Bio Solution's market cap has decreased from 218.31B to 159.99B, a decrease of -26.72%. That is a compound annual growth rate of -3.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 159.99B | -16.33% |
| Dec 30, 2025 | 191.20B | 10.84% |
| Dec 30, 2024 | 172.51B | 10.88% |
| Dec 28, 2023 | 155.58B | 82.92% |
| Dec 29, 2022 | 85.05B | -50.94% |
| Dec 30, 2021 | 173.35B | -26.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| S.Biomedics | 214.39B |
| Kangstem Biotech | 212.56B |
| curacle co.,ltd. | 184.07B |
| Genome & Company | 171.97B |
| Kanaph Therapeutics | 165.89B |
| Ensol Biosciences | 161.47B |
| NIBEC | 160.29B |
| Y-Biologics | 143.37B |